Can a beta-blocker help a common type of heart failure? new study investigates.
NCT ID NCT05553314
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a slow-release form of the beta-blocker carvedilol can improve heart function in people with heart failure with preserved ejection fraction (HFpEF), a condition where the heart pumps normally but is too stiff. 63 adults with high blood pressure and signs of heart strain took either the drug or a placebo for 6 months. Researchers measured changes in a blood marker (NT-proBNP) and heart muscle strain (GLS) to see if the drug helps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BETA-BLOCKER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Samsung Medical Center
Seoul, Il-won, 06351, South Korea
-
Wonju Severance Christian Hospital
Wŏnju, WONJU, 26426, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can shedding pounds reboot the Heart's exercise engine?
- Keto vs. Low-Fat: which diet helps heart failure patients move better?
- Zapping lung nerves could ease heart Failure-Related high blood pressure
- Stiff arteries may hold key to heart failure progression
- Simple breathing training may ease heart failure symptoms in seniors
- Could a single iron infusion ease heart failure in seniors?